C57BL/6N-Fbxo7tm1b(EUCOMM)Wtsi/WtsiCnrm

Status

Available to order

EMMA IDEM:14231
International strain nameC57BL/6N-Fbxo7tm1b(EUCOMM)Wtsi/WtsiCnrm
Alternative nameEPD0622_3_D02
Strain typeTargeted Mutant Strains
Allele/Transgene symbolFbxo7tm1b(EUCOMM)Wtsi
Gene/Transgene symbolFbxo7
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0622_3_D02. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele using a cell permeable HTN-Cre as described in doi:10.1007/s11248-013-9764-x. Click here for more information on EUCOMM final vectors.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • decreased leukocyte cell number / IMPC
  • decreased circulating iron level / IMPC
  • decreased hemoglobin content / IMPC
  • decreased erythrocyte cell number / IMPC
  • thrombocytosis / IMPC
  • hyperplasia / IMPC
  • atrophy / IMPC
  • extramedullary hemopoiesis / IMPC
  • decreased circulating fructosamine level / IMPC
  • hypoplasia / IMPC
  • increased circulating sodium level / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • male infertility / IMPC
  • decreased hematocrit / IMPC
  • increased red blood cell distribution width / IMPC
  • process of degenerative change / IMPC
  • increased circulating bilirubin level / IMPC
MGI phenotypes (gene matching)
  • abnormal proerythroblast morphology / MGI
  • increased erythroid progenitor cell number / MGI
  • increased pro-B cell number / MGI
  • decreased erythroblast number / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).